{ "labelLang" : "hun", "responseDate" : "2024-03-29 08:18", "content" : { "otype" : "JournalArticle", "mtid" : 31646872, "status" : "APPROVED", "published" : true, "comment" : "Division of Rheumatology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary \n Division of Hematology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary \n Division of Clinical Immunology, Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary \n Department of Oncology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary \n Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary \n Department of Pulmonology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary \n National Institute of Rheumatology and Physiotherapy, Budapest, Hungary \n Buda Hospital of the Hospitaller Order of Saint John of God, Budapest, Hungary \n Department of Rheumatology, Borsod-Abaúj-Zemplén County Hospital and University Teaching Hospital, Miskolc, Hungary \n Institute of Immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway \n Cited By :5 \n Export Date: 14 April 2022 \n CODEN: ARUEB \n Correspondence Address: Szekanecz, Z.; Division of Rheumatology, Nagyerdei street 98, Hungary; email: szekanecz.zoltan@med.unideb.hu", "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2024-02-21T00:03:07.775+0000", "lastModified" : "2023-09-19T18:47:32.440+0000", "created" : "2020-11-02T13:15:00.679+0000", "creator" : { "otype" : "Admin", "mtid" : 10028537, "link" : "/api/admin/10028537", "label" : "Baczkó Gabriella (SZTE ÁOK admin5 Reuma és Farmakológia)", "familyName" : "Baczkó", "givenName" : "Gabriella", "published" : true, "oldId" : 10028537, "snippet" : true }, "lastDuplumSearch" : "2024-03-01T02:55:09.154+0000", "core" : true, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 10000359, "link" : "/api/subtype/10000359", "label" : "Sokszerzős vagy csoportos szerzőségű szakcikk (Folyóiratcikk)", "name" : "Sokszerzős vagy csoportos szerzőségű szakcikk", "nameEng" : "Study Group", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 104, "published" : true, "oldId" : 10000359, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Szekanecz, Z.", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 93918110, "link" : "/api/authorship/93918110", "label" : "Szekanecz, Z. ✉ [Szekanecz, Zoltán (Reumatológia), szerző] Belgyógyászati Intézet (DE / ÁOK); Reumatológiai Tanszék (DE / ÁOK / BelgyI)", "listPosition" : 1, "share" : 0.053, "first" : true, "last" : false, "corresponding" : true, "author" : { "otype" : "Author", "mtid" : 10003464, "link" : "/api/author/10003464", "label" : "Szekanecz Zoltán (Reumatológia)", "familyName" : "Szekanecz", "givenName" : "Zoltán", "published" : true, "oldId" : 10003464, "snippet" : true }, "familyName" : "Szekanecz", "givenName" : "Z.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918111, "link" : "/api/authorship/93918111", "label" : "Gomez, I. [Gomez, Izabella Ilona (Reumatológia), szerző]", "listPosition" : 2, "share" : 0.053, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10051675, "link" : "/api/author/10051675", "label" : "Gomez Izabella Ilona (Reumatológia)", "familyName" : "Gomez", "givenName" : "Izabella Ilona", "published" : true, "oldId" : 10051675, "snippet" : true }, "familyName" : "Gomez", "givenName" : "I.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918112, "link" : "/api/authorship/93918112", "label" : "Soós, B.", "listPosition" : 3, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Soós", "givenName" : "B.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918113, "link" : "/api/authorship/93918113", "label" : "Bodoki, Levente [Bodoki, Levente (orvostudomány), szerző] Belgyógyászati Intézet (DE / ÁOK); Reumatológiai Tanszék (DE / ÁOK / BelgyI)", "listPosition" : 4, "share" : 0.053, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10047408, "link" : "/api/author/10047408", "label" : "Bodoki Levente (orvostudomány)", "familyName" : "Bodoki", "givenName" : "Levente", "published" : true, "oldId" : 10047408, "snippet" : true }, "familyName" : "Bodoki", "givenName" : "Levente", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918114, "link" : "/api/authorship/93918114", "label" : "Szamosi, S. [Szamosi, Szilvia (belgyógyászat, re...), szerző] Belgyógyászati Intézet (DE / ÁOK); Reumatológiai Tanszék (DE / ÁOK / BelgyI)", "listPosition" : 5, "share" : 0.053, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10048806, "link" : "/api/author/10048806", "label" : "Szamosi Szilvia (belgyógyászat, reumatológia, klinikai immunológia és allergológia)", "familyName" : "Szamosi", "givenName" : "Szilvia", "published" : true, "oldId" : 10048806, "snippet" : true }, "familyName" : "Szamosi", "givenName" : "S.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918115, "link" : "/api/authorship/93918115", "label" : "András, C. [András, Csilla (Onkológia), szerző] Onkológiai Tanszék (DE / ÁOK)", "listPosition" : 6, "share" : 0.053, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10039128, "link" : "/api/author/10039128", "label" : "András Csilla (Onkológia)", "familyName" : "András", "givenName" : "Csilla", "published" : true, "oldId" : 10039128, "snippet" : true }, "familyName" : "András", "givenName" : "C.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918116, "link" : "/api/authorship/93918116", "label" : "Juhász, B.", "listPosition" : 7, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Juhász", "givenName" : "B.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918117, "link" : "/api/authorship/93918117", "label" : "Váróczy, L.", "listPosition" : 8, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Váróczy", "givenName" : "L.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918118, "link" : "/api/authorship/93918118", "label" : "Antal-Szalmás, P. [Antal-Szalmás, Péter (Immunológia), szerző] Laboratóriumi Medicina Intézet (DE / ÁOK)", "listPosition" : 9, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10009455, "link" : "/api/author/10009455", "label" : "Antal-Szalmás Péter (Immunológia)", "familyName" : "Antal-Szalmás", "givenName" : "Péter", "published" : true, "oldId" : 10009455, "snippet" : true }, "familyName" : "Antal-Szalmás", "givenName" : "P.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918119, "link" : "/api/authorship/93918119", "label" : "Szodoray, P.", "listPosition" : 10, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Szodoray", "givenName" : "P.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918120, "link" : "/api/authorship/93918120", "label" : "Bittner, N.", "listPosition" : 11, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Bittner", "givenName" : "N.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918121, "link" : "/api/authorship/93918121", "label" : "Árkosy, Péter [Árkosy, Péter (onkológia, sebészet), szerző] Onkológiai Tanszék (DE / ÁOK)", "listPosition" : 12, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10060464, "link" : "/api/author/10060464", "label" : "Árkosy Péter (onkológia, sebészet)", "familyName" : "Árkosy", "givenName" : "Péter", "published" : true, "oldId" : 10060464, "snippet" : true }, "familyName" : "Árkosy", "givenName" : "Péter", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918122, "link" : "/api/authorship/93918122", "label" : "Illés, Á. [Illés, Árpád (Orvostudományok), szerző] Belgyógyászati Intézet (DE / ÁOK)", "listPosition" : 13, "share" : 0.053, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10013875, "link" : "/api/author/10013875", "label" : "Illés Árpád (Orvostudományok)", "familyName" : "Illés", "givenName" : "Árpád", "published" : true, "oldId" : 10013875, "snippet" : true }, "familyName" : "Illés", "givenName" : "Á.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918123, "link" : "/api/authorship/93918123", "label" : "Szűcs, Gabriella [Szűcs, Gabriella (Reumatológia, all...), szerző] Belgyógyászati Intézet (DE / ÁOK); Reumatológiai Tanszék (DE / ÁOK / BelgyI)", "listPosition" : 14, "share" : 0.053, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10030837, "link" : "/api/author/10030837", "label" : "Szűcs Gabriella (Reumatológia, allergológia és klinikai immunológia, belgyógyászat)", "familyName" : "Szűcs", "givenName" : "Gabriella", "published" : true, "oldId" : 10030837, "snippet" : true }, "familyName" : "Szűcs", "givenName" : "Gabriella", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918124, "link" : "/api/authorship/93918124", "label" : "Dankó, K. [Dankó, Katalin (Immunológia), szerző] Belgyógyászati Intézet (DE / ÁOK); Klinikai Immunológiai Tanszék (DE / ÁOK / BelgyI)", "listPosition" : 15, "share" : 0.053, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10009398, "link" : "/api/author/10009398", "label" : "Dankó Katalin (Immunológia)", "familyName" : "Dankó", "givenName" : "Katalin", "published" : true, "oldId" : 10009398, "snippet" : true }, "familyName" : "Dankó", "givenName" : "K.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918125, "link" : "/api/authorship/93918125", "label" : "Bender, T. [Bender, Tamás (Balneoterápia, me...), szerző] Budai Irgalmasrendi Kórház Kht.", "listPosition" : 16, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10013912, "link" : "/api/author/10013912", "label" : "Bender Tamás (Balneoterápia, medicina)", "familyName" : "Bender", "givenName" : "Tamás", "published" : true, "oldId" : 10013912, "snippet" : true }, "familyName" : "Bender", "givenName" : "T.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918126, "link" : "/api/authorship/93918126", "label" : "Tamási, L.", "listPosition" : 17, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "familyName" : "Tamási", "givenName" : "L.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918127, "link" : "/api/authorship/93918127", "label" : "Szekanecz, É. [Szekanecz, Éva (klinikai onkológi...), szerző] Onkológiai Tanszék (DE / ÁOK)", "listPosition" : 18, "share" : 0.05263158, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10043694, "link" : "/api/author/10043694", "label" : "Szekanecz Éva (klinikai onkológia, fül-orr-gégészet)", "familyName" : "Szekanecz", "givenName" : "Éva", "published" : true, "oldId" : 10043694, "snippet" : true }, "familyName" : "Szekanecz", "givenName" : "É.", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 93918128, "link" : "/api/authorship/93918128", "label" : "on, behalf of the Hungarian OncoRheumatology Network (HORN) initiative", "listPosition" : 19, "share" : 0.05263158, "first" : false, "last" : true, "corresponding" : false, "familyName" : "on", "givenName" : "behalf of the Hungarian OncoRheumatology Network (HORN) initiative", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 17851175, "link" : "/api/publicationidentifier/17851175", "label" : "DOI: 10.1016/j.autrev.2020.102658", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1016/j.autrev.2020.102658", "realUrl" : "https://doi.org/10.1016/j.autrev.2020.102658", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 17874213, "link" : "/api/publicationidentifier/17874213", "label" : "WoS: 000579751000001", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "000579751000001", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/000579751000001", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 17851174, "link" : "/api/publicationidentifier/17851174", "label" : "Scopus: 85091217953", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85091217953", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85091217953", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 17874214, "link" : "/api/publicationidentifier/17874214", "label" : "PubMed: 32942035", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "32942035", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=32942035&dopt=Abstract", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 20526016, "link" : "/api/publicationidentifier/20526016", "label" : "Egyéb URL: https://linkinghub.elsevier.com/retrieve/pii/S1568997220302330", "source" : { "otype" : "PlainSource", "mtid" : 40, "link" : "/api/publicationsource/40", "label" : "Egyéb URL", "type" : { "otype" : "PublicationSourceType", "mtid" : 10006, "link" : "/api/publicationsourcetype/10006", "label" : "Link", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "Egyéb URL", "nameEng" : "Other URL", "linkPattern" : "@@@", "publiclyVisible" : true, "published" : true, "oldId" : 40, "snippet" : true }, "oaType" : "NONE", "validState" : "IDENTICAL", "idValue" : "https://linkinghub.elsevier.com/retrieve/pii/S1568997220302330", "realUrl" : "https://linkinghub.elsevier.com/retrieve/pii/S1568997220302330", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 2149050, "link" : "/api/journal/2149050", "label" : "AUTOIMMUNITY REVIEWS 1568-9972 1873-0183", "pIssn" : "1568-9972", "eIssn" : "1873-0183", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 2149050, "snippet" : true }, "volume" : "19", "issue" : "11", "internalId" : "102658", "firstPageOrInternalIdForSort" : "102658", "publishedYear" : 2020, "abstractText" : "Oncorheumatology: relationship between malignancies and musculoskeletal diseases: Oncorheumatology is the meeting point of tumor formation and rheumatic musculoskeletal diseases (RMD). Multiple interactions exist between these two medical specialties. One major field is the topic of malignancies associated with rheumatic diseases, while the other topic covers the development of musculoskeletal disease in cancer patients. Within the first group, secondary malignancies may be associated with rheumatic diseases. Mostly sustained inflammation is responsible for transition into cancer. Tumor-associated antigens (TAA) with adhesive properties are present on tumor cells. These molecules may also be expressed by inflammatory leukocytes and soluble TAA levels may be elevated in RMDs. There has been continuous debate with respect to the possible carcinogenicity of conventional and targeted antirheumatic drugs. Very recent data from registries suggest that neither biologics, nor JAK inhibitors increase cancer risk in arthritis patients. The issue of physiotherapy in rheumatic patients with recent or current cancer has also been controversial. Some modalities, primarily exercise, may be safely applied to patients with RMD and cancer. The second large topic includes paraneoplastic syndromes. Musculoskeletal paraneoplasias are triggered by tumor-derived mediators. These syndromes are sometimes slightly different from the classical RMDs. Various chemotherapies may also be associated with autoimmune side effects. Recently, these immune-related complications have also been observed in cancer patients treated with immune-checkpoint inhibitors. Sex hormone-deprivation therapies, such as aromatase inhibitors and anti-androgens are widely used for the treatment of breast and prostate cancer, respectively. These compounds may induce bone loss and lead to osteoporosis. Finally, primary and secondary malignancies of the musculoskeletal system may also interest rheumatologists. In this review, the clinical, practical aspects of these eight pillars of oncorheumatology will be discussed. © 2020 The Authors", "fundings" : [ { "otype" : "Funding", "mtid" : 1994731, "link" : "/api/funding/1994731", "label" : "(GINOP-2.3.2-15-2016-00015) Támogató: GINOP", "published" : false, "snippet" : true } ], "keywords" : [ { "otype" : "Keyword", "mtid" : 2452, "link" : "/api/keyword/2452", "label" : "TUMORS", "published" : true, "oldId" : 2452, "snippet" : true }, { "otype" : "Keyword", "mtid" : 16728, "link" : "/api/keyword/16728", "label" : "targeted therapy", "published" : true, "oldId" : 16728, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1001255, "link" : "/api/keyword/1001255", "label" : "SARCOMAS", "published" : true, "oldId" : 1001255, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1007711, "link" : "/api/keyword/1007711", "label" : "Carcinogenicity", "published" : true, "oldId" : 1007711, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1053000, "link" : "/api/keyword/1053000", "label" : "Musculoskeletal Diseases", "published" : true, "oldId" : 1053000, "snippet" : true }, { "otype" : "Keyword", "mtid" : 1741174, "link" : "/api/keyword/1741174", "label" : "immune-checkpoint inhibition", "published" : true, "snippet" : true }, { "otype" : "Keyword", "mtid" : 2029386, "link" : "/api/keyword/2029386", "label" : "oncorheumatology", "published" : true, "snippet" : true }, { "otype" : "Keyword", "mtid" : 2186537, "link" : "/api/keyword/2186537", "label" : "Secondary tumor development", "published" : true, "snippet" : true } ], "digital" : null, "printed" : null, "sourceYear" : 2020, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : true, "missingAuthor" : false, "oaType" : "NONE", "oaCheckDate" : "2024-02-21", "oaFree" : false, "citationCount" : 11, "citationCountUnpublished" : 0, "citationCountWoOther" : 11, "independentCitCountWoOther" : 9, "nationalOriginCitationCount" : 2, "foreignEditionCitationCount" : 10, "doiCitationCount" : 10, "wosCitationCount" : 9, "scopusCitationCount" : 10, "wosScopusCitationCount" : 11, "wosScopusCitationCountWoOther" : 11, "wosScopusIndependentCitationCount" : 9, "wosScopusIndependentCitationCountWoOther" : 9, "independentCitationCount" : 9, "selfCitationCount" : 2, "unhandledCitationCount" : 0, "citingPubCount" : 11, "independentCitingPubCount" : 9, "citingPubCountWoOther" : 11, "independentCitingPubCountWoOther" : 9, "unhandledCitingPubCount" : 0, "citedPubCount" : 25, "citedCount" : 25, "pubStats" : { "types" : [ { "type" : "Folyóiratcikk", "typeEng" : "Journal Article", "code" : 24, "count" : 10 }, { "type" : "Könyvrészlet", "typeEng" : "Chapter in Book", "code" : 25, "count" : 1 }, { "type" : "Könyv", "typeEng" : "Book", "code" : 23, "count" : 0 }, { "type" : "Egyéb konferenciaközlemény", "typeEng" : "Conference paper", "code" : 31, "count" : 0 }, { "type" : "Egyéb konferenciakötet", "typeEng" : "Conference proceedings", "code" : 32, "count" : 0 }, { "type" : "Oltalmi formák", "typeEng" : "Protection forms", "code" : 26, "count" : 0 }, { "type" : "Disszertáció", "typeEng" : "Thesis", "code" : 28, "count" : 0 }, { "type" : "Egyéb", "typeEng" : "Miscellaneous", "code" : 29, "count" : 0 }, { "type" : "Alkotás", "typeEng" : "Achievement", "code" : 22, "count" : 0 }, { "type" : "Kutatási adat", "typeEng" : "Research data", "code" : 33, "count" : 0 } ], "citationTypes" : [ { "type" : "Folyóiratcikk", "typeEng" : "Journal Article", "code" : 24, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Könyvrészlet", "typeEng" : "Chapter in Book", "code" : 25, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Könyv", "typeEng" : "Book", "code" : 23, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Egyéb konferenciaközlemény", "typeEng" : "Conference paper", "code" : 31, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Egyéb konferenciakötet", "typeEng" : "Conference proceedings", "code" : 32, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Oltalmi formák", "typeEng" : "Protection forms", "code" : 26, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Disszertáció", "typeEng" : "Thesis", "code" : 28, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Egyéb", "typeEng" : "Miscellaneous", "code" : 29, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Alkotás", "typeEng" : "Achievement", "code" : 22, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Kutatási adat", "typeEng" : "Research data", "code" : 33, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 } ], "years" : [ { "year" : 2021, "publicationCount" : 0, "citationCount" : 3, "independentCitationCount" : 3, "citingPubCount" : 3, "independentCitingPubCount" : 3, "oaStats" : null, "oaStats2" : null }, { "year" : 2022, "publicationCount" : 0, "citationCount" : 5, "independentCitationCount" : 5, "citingPubCount" : 5, "independentCitingPubCount" : 5, "oaStats" : null, "oaStats2" : null }, { "year" : 2023, "publicationCount" : 0, "citationCount" : 2, "independentCitationCount" : 1, "citingPubCount" : 2, "independentCitingPubCount" : 1, "oaStats" : null, "oaStats2" : null }, { "year" : 2024, "publicationCount" : 0, "citationCount" : 1, "independentCitationCount" : 0, "citingPubCount" : 1, "independentCitingPubCount" : 0, "oaStats" : null, "oaStats2" : null } ] }, "ratings" : [ { "otype" : "SjrRating", "mtid" : 10820584, "link" : "/api/sjrrating/10820584", "label" : "sjr:Q1 (2020) Scopus - Immunology AUTOIMMUNITY REVIEWS 1568-9972", "listPos" : 28, "rankValue" : 0.24, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 2403, "link" : "/api/classificationexternal/2403", "label" : "Scopus - Immunology", "published" : true, "oldId" : 2403, "snippet" : true }, "ranking" : "Q1", "calculation" : "DIRECT", "published" : true, "snippet" : true } ], "ratingsForSort" : "Q1", "references" : [ { "otype" : "Reference", "mtid" : 492585, "link" : "/api/reference/492585", "label" : "1. Szendroi, M., Papai, Z., Koos, R., Illes, T., Limb-saving surgery, survival, and prognostic factors for osteosarcoma: the Hungarian experience (2000) J Surg Oncol, 73, pp. 87-94", "listPosition" : 1, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492584, "link" : "/api/reference/492584", "label" : "2. Ritter, J., Bielack, S.S., Osteosarcoma (2010) Ann Oncol, 21, pp. vii320-5", "listPosition" : 2, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492583, "link" : "/api/reference/492583", "label" : "3. Anderson, P.M., Bielack, S.S., Gorlick, R.G., Skubitz, K., Daw, N.C., Herzog, C.E., A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma (2016) Pediatr Blood Cancer, 63, pp. 1761-1770", "listPosition" : 3, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492582, "link" : "/api/reference/492582", "label" : "4. Szendroi, M., New aspects in the treatment of bone sarcomas (1994) Acta Med Hung, 50, pp. 237-244", "listPosition" : 4, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492581, "link" : "/api/reference/492581", "label" : "5. Grimer, R.J., Cannon, S.R., Taminiau, A.M., Bielack, S., Kempf-Bielack, B., Windhager, R., Osteosarcoma over the age of forty (2003) Eur J Cancer, 39, pp. 157-163", "listPosition" : 5, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492580, "link" : "/api/reference/492580", "label" : "6. Ellis, G.K., Bone, H.G., Chlebowski, R., Paul, D., Spadafora, S., Smith, J., Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer (2008) J Clin Oncol, 26, pp. 4875-4882", "listPosition" : 6, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492579, "link" : "/api/reference/492579", "label" : "7. Coleman, R., de Boer, R., Eidtmann, H., Llombart, A., Davidson, N., Neven, P., Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results (2013) Ann Oncol, 24, pp. 398-405", "listPosition" : 7, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492578, "link" : "/api/reference/492578", "label" : "8. Gnant, M., Mlineritsch, B., Luschin-Ebengreuth, G., Kainberger, F., Kassmann, H., Piswanger-Solkner, J.C., Study, adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy (2008) Lancet Oncol, 9, pp. 840-849", "listPosition" : 8, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492575, "link" : "/api/reference/492575", "label" : "9. Puzanov, I., Diab, A., Abdallah, K., Bingham, C.O., 3rd, Brogdon, C., Dadu, R., Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) toxicity management working group (2017) J Immunother Cancer, 5, p. 95", "listPosition" : 9, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492574, "link" : "/api/reference/492574", "label" : "10. Steven, N.M., Fisher, B.A., Management of rheumatic complications of immune checkpoint inhibitor therapy - an oncological perspective (2019) Rheumatology (Oxford), 58, pp. vii29-vii39", "listPosition" : 10, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492573, "link" : "/api/reference/492573", "label" : "11. Leipe, J., Mariette, X., Management of rheumatic complications of ICI therapy: a rheumatology viewpoint (2019) Rheumatology (Oxford), 58, pp. vii49-vii58", "listPosition" : 11, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492572, "link" : "/api/reference/492572", "label" : "12. Brahmer, J.R., Lacchetti, C., Schneider, B.J., Atkins, M.B., Brassil, K.J., Caterino, J.M., Cancer, management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology clinical practice guideline (2018) J Clin Oncol, 36, pp. 1714-1768", "listPosition" : 12, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492571, "link" : "/api/reference/492571", "label" : "13. Friedman, C.F., Proverbs-Singh, T.A., Postow, M.A., Treatment of the immune-related adverse effects of immune checkpoint inhibitors: a review (2016) JAMA Oncol, 2, pp. 1346-1353", "listPosition" : 13, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492570, "link" : "/api/reference/492570", "label" : "14. Le Mercier, I., Lines, J.L., Noelle, R.J., Beyond CTLA-4 and PD-1, the generation Z of negative checkpoint regulators (2015) Front Immunol, 6, p. 418", "listPosition" : 14, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492569, "link" : "/api/reference/492569", "label" : "15. Cappelli, L.C., Dorak, M.T., Bettinotti, M.P., Bingham, C.O., Shah, A.A., Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis (2019) Rheumatology (Oxford), 58, pp. 476-480", "listPosition" : 15, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492568, "link" : "/api/reference/492568", "label" : "16. Peled, M., Strazza, M., Azoulay-Alfaguter, I., Silverman, G.J., Scher, J.U., Mor, A., Analysis of programmed Death-1 in patients with psoriatic arthritis (2015) Inflammation, 38, pp. 1573-1579", "listPosition" : 16, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492567, "link" : "/api/reference/492567", "label" : "17. Salama, A.D., Chitnis, T., Imitola, J., Ansari, M.J., Akiba, H., Tushima, F., Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis (2003) J Exp Med, 198, pp. 71-78", "listPosition" : 17, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492566, "link" : "/api/reference/492566", "label" : "18. Raptopoulou, A.P., Bertsias, G., Makrygiannakis, D., Verginis, P., Kritikos, I., Tzardi, M., The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis (2010) Arthritis Rheum, 62, pp. 1870-1880", "listPosition" : 18, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492565, "link" : "/api/reference/492565", "label" : "19. Sebastiani, G.D., Scirocco, C., Galeazzi, M., Rheumatic immune related adverse events in patients treated with checkpoint inhibitors for immunotherapy of cancer (2019) Autoimmun Rev, 18, pp. 805-813", "listPosition" : 19, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492564, "link" : "/api/reference/492564", "label" : "20. Tocut, M., Brenner, R., Zandman-Goddard, G., Autoimmune phenomena and disease in cancer patients treated with immune checkpoint inhibitors (2018) Autoimmun Rev, 17, pp. 610-616", "listPosition" : 20, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492563, "link" : "/api/reference/492563", "label" : "21. Postow, M.A., Sidlow, R., Hellmann, M.D., Immune-related adverse events associated with immune checkpoint blockade (2018) N Engl J Med, 378, pp. 158-168", "listPosition" : 21, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492561, "link" : "/api/reference/492561", "label" : "22. Calabrese, L.H., Calabrese, C., Cappelli, L.C., Rheumatic immune-related adverse events from cancer immunotherapy (2018) Nat Rev Rheumatol, 14, pp. 569-579", "listPosition" : 22, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492560, "link" : "/api/reference/492560", "label" : "23. Bertrand, A., Kostine, M., Barnetche, T., Truchetet, M.E., Schaeverbeke, T., Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis (2015) BMC Med, 13, p. 211", "listPosition" : 23, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492559, "link" : "/api/reference/492559", "label" : "24. Arnaud, L., Lebrun-Vignes, B., Salem, J.E., Checkpoint inhibitor-associated immune arthritis (2019) Ann Rheum Dis, 78, p. e68", "listPosition" : 24, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492558, "link" : "/api/reference/492558", "label" : "25. Lidar, M., Giat, E., Garelick, D., Horowitz, Y., Amital, H., Steinberg-Silman, Y., Rheumatic manifestations among cancer patients treated with immune checkpoint inhibitors (2018) Autoimmun Rev, 17, pp. 284-289", "listPosition" : 25, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492557, "link" : "/api/reference/492557", "label" : "26. Calabrese, L., Velcheti, V., Checkpoint immunotherapy: good for cancer therapy, bad for rheumatic diseases (2017) Ann Rheum Dis, 76, pp. 1-3", "listPosition" : 26, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492556, "link" : "/api/reference/492556", "label" : "27. Dai, S., Jia, R., Zhang, X., Fang, Q., Huang, L., The PD-1/PD-Ls pathway and autoimmune diseases (2014) Cell Immunol, 290, pp. 72-79", "listPosition" : 27, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492555, "link" : "/api/reference/492555", "label" : "28. Szekanecz, E., Szekanecz, Z., [autoimmune side effects of immune-checkpoint inhibitor therapies in oncology: pathogenesis, clinic and treatment], hung (2019) Medizinhist J, 160, pp. 887-895", "listPosition" : 28, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492554, "link" : "/api/reference/492554", "label" : "29. Chinai, J.M., Janakiram, M., Chen, F., Chen, W., Kaplan, M., Zang, X., New immunotherapies targeting the PD-1 pathway (2015) Trends Pharmacol Sci, 36, pp. 587-595", "listPosition" : 29, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492553, "link" : "/api/reference/492553", "label" : "30. Szekanecz, Z., Szekanecz, É., Immunological and immunooncological role of PD-1 and PD-L1 (2017) Immunol Quarterly (Budapest), 9, pp. 23-27", "listPosition" : 30, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492552, "link" : "/api/reference/492552", "label" : "31. Welsh, S.J., Corrie, P.G., Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma (2015) Ther Adv Med Oncol, 7, pp. 122-136", "listPosition" : 31, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492551, "link" : "/api/reference/492551", "label" : "32. Coleman, R.E., Rathbone, E., Brown, J.E., Management of cancer treatment-induced bone loss (2013) Nat Rev Rheumatol, 9, pp. 365-374", "listPosition" : 32, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492550, "link" : "/api/reference/492550", "label" : "33. Khouri, C., Blaise, S., Carpentier, P., Villier, C., Cracowski, J.L., Roustit, M., Drug-induced Raynaud's phenomenon: beyond beta-adrenoceptor blockers (2016) Br J Clin Pharmacol, 82, pp. 6-16", "listPosition" : 33, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492549, "link" : "/api/reference/492549", "label" : "34. Raanani, P., Ben-Bassat, I., Immune-mediated complications during interferon therapy in hematological patients (2002) Acta Haematol, 107, pp. 133-144", "listPosition" : 34, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492547, "link" : "/api/reference/492547", "label" : "35. Waning, D.L., Guise, T.A., Molecular mechanisms of bone metastasis and associated muscle weakness (2014) Clin Cancer Res, 20, pp. 3071-3077", "listPosition" : 35, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492546, "link" : "/api/reference/492546", "label" : "36. Dickinson, C.J., The aetiology of clubbing and hypertrophic osteoarthropathy (1993) Eur J Clin Invest, 23, pp. 330-338", "listPosition" : 36, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492545, "link" : "/api/reference/492545", "label" : "37. Soltesz, P., Szekanecz, Z., Vegh, J., Lakos, G., Toth, L., Szakall, S., Catastrophic antiphospholipid syndrome in cancer (2000) Haematologia (Budap), 30, pp. 303-311", "listPosition" : 37, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492544, "link" : "/api/reference/492544", "label" : "38. Soltesz, P., Szekanecz, Z., Vegh, J., Lakos, G., Toth, L., Szakall, S., Catastrophic antiphospholipid antibody syndrome in a cancer patient (1999) Orv Hetil, 140, pp. 2917-2920", "listPosition" : 38, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492543, "link" : "/api/reference/492543", "label" : "39. Tincani, A., Taraborelli, M., Cattaneo, R., Antiphospholipid antibodies and malignancies (2010) Autoimmun Rev, 9, pp. 200-202", "listPosition" : 39, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492542, "link" : "/api/reference/492542", "label" : "40. Font, C., Vidal, L., Espinosa, G., Tassies, D., Monteagudo, J., Farrus, B., Solid cancer, antiphospholipid antibodies, and venous thromboembolism (2011) Autoimmun Rev, 10, pp. 222-227", "listPosition" : 40, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492541, "link" : "/api/reference/492541", "label" : "41. Racanelli, V., Prete, M., Minoia, C., Favoino, E., Perosa, F., Rheumatic disorders as paraneoplastic syndromes (2008) Autoimmun Rev, 7, pp. 352-358", "listPosition" : 41, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492540, "link" : "/api/reference/492540", "label" : "42. Geng, G., Yu, X., Jiang, J., Yu, X., Aetiology and pathogenesis of paraneoplastic autoimmune disorders (2020) Autoimmun Rev, 19", "listPosition" : 42, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492539, "link" : "/api/reference/492539", "label" : "43. András, C., Szántó, J., Szekanecz, Z., Csiki, Z., Illés, Á., Szekanecz, É., Clinical importance of paraneoplasias in rheumatology (2006) Hung Immunol, 5, pp. 4-11", "listPosition" : 43, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492538, "link" : "/api/reference/492538", "label" : "44. Manger, B., Schett, G., Paraneoplastic syndromes in rheumatology (2014) Nat Rev Rheumatol, 10, pp. 662-670", "listPosition" : 44, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492537, "link" : "/api/reference/492537", "label" : "45. Siqueira, R.B.A., Freitas-Junior, R., Lopes, P.S., Lagares, M.S., Viana, F.P., Mesquita, T., Hydrotherapy following breast cancer surgery phase II trial on hydrotherapy in women following breast cancer surgery (2020) Breast J, 26, pp. 1107-1110", "listPosition" : 45, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492536, "link" : "/api/reference/492536", "label" : "46. Kotenko, K.V., Kruglova, L.S., Korchazhkina, N.B., Shatokhina, E.A., Marionov, V.E., Physical therapy methods for treatment and rehabilitation of oncologic patients (review of literature) (2016) Med Tr Prom Ekol, pp. 24-29", "listPosition" : 46, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492535, "link" : "/api/reference/492535", "label" : "47. Buffart, L.M., Kalter, J., Sweegers, M.G., Courneya, K.S., Newton, R.U., Aaronson, N.K., Effects and moderators of exercise on quality of life and physical function in patients with cancer: an individual patient data meta-analysis of 34 RCTs (2017) Cancer Treat Rev, 52, pp. 91-104", "listPosition" : 47, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492534, "link" : "/api/reference/492534", "label" : "48. Gomez, I., Szekanecz, E., Szekanecz, Z., Bender, T., Physiotherapy of cancer patients (2016) Hung Med J, 157, pp. 1224-1231", "listPosition" : 48, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492533, "link" : "/api/reference/492533", "label" : "49. Raaschou, P., Soderling, J., Turesson, C., Askling, J., A.S. Group, Tumor necrosis factor inhibitors and Cancer recurrence in Swedish patients with rheumatoid arthritis: a Nationwide population-based cohort study (2018) Ann Intern Med, 169, pp. 291-299", "listPosition" : 49, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492532, "link" : "/api/reference/492532", "label" : "50. Thompson, A.E., Rieder, S.W., Pope, J.E., Tumor necrosis factor therapy and the risk of serious infection and malignancy in patients with early rheumatoid arthritis: a meta-analysis of randomized controlled trials (2011) Arthritis Rheum, 63, pp. 1479-1485", "listPosition" : 50, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492531, "link" : "/api/reference/492531", "label" : "51. Genovese, M.C., Fleischmann, R., Combe, B., Hall, S., Rubbert-Roth, A., Zhang, Y., Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial (2018) Lancet, 391, pp. 2513-2524", "listPosition" : 51, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492530, "link" : "/api/reference/492530", "label" : "52. Burmester, G.R., Kremer, J.M., Van den Bosch, F., Kivitz, A., Bessette, L., Li, Y., Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial (2018) Lancet, 391, pp. 2503-2512", "listPosition" : 52, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492529, "link" : "/api/reference/492529", "label" : "53. Choy, E.H.S., Miceli-Richard, C., Gonzalez-Gay, M.A., Sinigaglia, L., Schlichting, D.E., Meszaros, G., The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib (2019) Clin Exp Rheumatol, 37, pp. 694-704", "listPosition" : 53, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492528, "link" : "/api/reference/492528", "label" : "54. van Vollenhoven, R., Helt, C., Arora, V., Zhong, J., Correia, A.P., de la Torre, I., Safety and efficacy of Baricitinib in patients receiving conventional synthetic disease-modifying antirheumatic drugs or corticosteroids (2018) Rheumatol Therapy, 5, pp. 525-536", "listPosition" : 54, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492527, "link" : "/api/reference/492527", "label" : "55. Harigai, M., Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis (2019) Rheumatology (Oxford), 58, pp. i34-i42", "listPosition" : 55, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492526, "link" : "/api/reference/492526", "label" : "56. Curtis, J.R., Lee, E.B., Kaplan, I.V., Kwok, K., Geier, J., Benda, B., Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme (2016) Ann Rheum Dis, 75, pp. 831-841", "listPosition" : 56, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492525, "link" : "/api/reference/492525", "label" : "57. Sivaraman, P., Cohen, S.B., Malignancy and Janus kinase inhibition (2017) Rheum Dis Clin North Am, 43, pp. 79-93", "listPosition" : 57, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492524, "link" : "/api/reference/492524", "label" : "58. Rubbert-Roth, A., Sebba, A., Brockwell, L., Kelman, A., Porter-Brown, B., Pulley, J., Malignancy rates in patients with rheumatoid arthritis treated with tocilizumab (2016) RMD Open, 2", "listPosition" : 58, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492523, "link" : "/api/reference/492523", "label" : "59. Lopez-Olivo, M.A., Tayar, J.H., Martinez-Lopez, J.A., Pollono, E.N., Cueto, J.P., Gonzales-Crespo, M.R., Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis (2012) JAMA, 308, pp. 898-908", "listPosition" : 59, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492522, "link" : "/api/reference/492522", "label" : "60. Strangfeld, A., Hierse, F., Rau, R., Burmester, G.R., Krummel-Lorenz, B., Demary, W., Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT (2010) Arthritis Res Ther, 12, p. R5", "listPosition" : 60, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492521, "link" : "/api/reference/492521", "label" : "61. Szekanecz, Z., Szanto, S., Szabo, Z., Vancsa, A., Szamosi, S., Bodnar, N., Biologics - beyond the joints (2010) Autoimmun Rev, 9, pp. 820-824", "listPosition" : 61, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492520, "link" : "/api/reference/492520", "label" : "62. Cush, J.J., Dao, K.H., Malignancy risks with biologic therapies (2012) Rheum Dis Clin North Am, 38, pp. 761-770", "listPosition" : 62, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492519, "link" : "/api/reference/492519", "label" : "63. Bongartz, T., Sutton, A.J., Sweeting, M.J., Buchan, I., Matteson, E.L., Montori, V., Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials (2006) JAMA, 295, pp. 2275-2285", "listPosition" : 63, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492518, "link" : "/api/reference/492518", "label" : "64. Alhefdhi, A., Burke, J.F., Redlich, A., Kunnimalaiyaan, M., Chen, H., Leflunomide suppresses growth in human medullary thyroid cancer cells (2013) J Surg Res, 185, pp. 212-216", "listPosition" : 64, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492517, "link" : "/api/reference/492517", "label" : "65. Zhang, C., Chu, M., Leflunomide: a promising drug with good antitumor potential (2018) Biochem Biophys Res Commun, 496, pp. 726-730", "listPosition" : 65, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492516, "link" : "/api/reference/492516", "label" : "66. Behrens, F., Koehm, M., Burkhardt, H., Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses (2011) Curr Opin Rheumatol, 23, pp. 282-287", "listPosition" : 66, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492515, "link" : "/api/reference/492515", "label" : "67. Solomon, D.H., Kremer, J.M., Fisher, M., Curtis, J.R., Furer, V., Harrold, L.R., Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs (2014) Semin Arthritis Rheum, 43, pp. 489-497", "listPosition" : 67, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492514, "link" : "/api/reference/492514", "label" : "68. Buchbinder, R., Barber, M., Heuzenroeder, L., Wluka, A.E., Giles, G., Hall, S., Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate (2008) Arthritis Rheum, 59, pp. 794-799", "listPosition" : 68, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492513, "link" : "/api/reference/492513", "label" : "69. Wadstrom, H., Frisell, T., Askling, J., Anti, G., Rheumatic therapy in Sweden study, malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, Tocilizumab, Abatacept, or rituximab in clinical practice: a Nationwide cohort study from Sweden (2017) JAMA Intern Med, 177, pp. 1605-1612", "listPosition" : 69, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492512, "link" : "/api/reference/492512", "label" : "70. Mercer, L.K., Lunt, M., Low, A.L., Dixon, W.G., Watson, K.D., Symmons, D.P., Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology biologics register for rheumatoid arthritis (2015) Ann Rheum Dis, 74, pp. 1087-1093", "listPosition" : 70, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492511, "link" : "/api/reference/492511", "label" : "71. Mercer, L.K., Davies, R., Galloway, J.B., Low, A., Lunt, M., Dixon, W.G., C. British Society for Rheumatology biologics register control centre, risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population (2013) Rheumatology (Oxford), 52, pp. 91-98", "listPosition" : 71, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492510, "link" : "/api/reference/492510", "label" : "72. Sepriano, A., Kerschbaumer, A., Smolen, J.S., van der Heijde, D., Dougados, M., van Vollenhoven, R., Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis (2020) Ann Rheum Dis, 79, pp. 760-770", "listPosition" : 72, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492509, "link" : "/api/reference/492509", "label" : "73. Ramiro, S., Gaujoux-Viala, C., Nam, J.L., Smolen, J.S., Buch, M., Gossec, L., Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis (2014) Ann Rheum Dis, 73, pp. 529-535", "listPosition" : 73, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492508, "link" : "/api/reference/492508", "label" : "74. Smolen, J.S., van der Heijde, D., Machold, K.P., Aletaha, D., Landewe, R., Proposal for a new nomenclature of disease-modifying antirheumatic drugs (2014) Ann Rheum Dis, 73, pp. 3-5", "listPosition" : 74, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492507, "link" : "/api/reference/492507", "label" : "75. Safadi, R., Ligumsky, M., Goldin, E., Ilan, Y., Haviv, Y.S., Nusair, S., Increased serum CA 19-9 antibodies in Sjogren's syndrome (1998) Postgrad Med J, 74, pp. 543-544", "listPosition" : 75, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492506, "link" : "/api/reference/492506", "label" : "76. Kimura, K., Ezoe, K., Yokozeki, H., Katayama, I., Nishioka, K., Elevated serum CA125 in progressive systemic sclerosis with pleural effusion (1995) J Dermatol, 22, pp. 28-31", "listPosition" : 76, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492505, "link" : "/api/reference/492505", "label" : "77. Szekanecz, Z., Haines, G.K., Harlow, L.A., Shah, M.R., Fong, T.W., Fu, R., Increased synovial expression of the adhesion molecules CD66a, CD66b, and CD31 in rheumatoid and osteoarthritis (1995) Clin Immunol Immunopathol, 76, pp. 180-186", "listPosition" : 77, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492504, "link" : "/api/reference/492504", "label" : "78. Szekanecz, E., Szucs, G., Szekanecz, Z., Tarr, T., Antal-Szalmas, P., Szamosi, S., Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices (2008) J Autoimmun, 31, pp. 372-376", "listPosition" : 78, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492503, "link" : "/api/reference/492503", "label" : "79. Szekanecz, E., Sandor, Z., Antal-Szalmas, P., Soos, L., Lakos, G., Besenyei, T., Increased production of the soluble tumor-associated antigens CA19-9, CA125, and CA15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation? (2007) Ann N Y Acad Sci, 1108, pp. 359-371", "listPosition" : 79, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492502, "link" : "/api/reference/492502", "label" : "80. De Luca, F., Shoenfeld, Y., The microbiome in autoimmune diseases (2018) Clin Exp Immunol, 195, pp. 74-85", "listPosition" : 80, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492501, "link" : "/api/reference/492501", "label" : "81. Uronis, J.M., Muhlbauer, M., Herfarth, H.H., Rubinas, T.C., Jones, G.S., Jobin, C., Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility (2009) PLoS One, 4, p. e6026", "listPosition" : 81, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492500, "link" : "/api/reference/492500", "label" : "82. Polk, D.B., Peek, R.M., Jr., Helicobacter pylori: gastric cancer and beyond (2010) Nat Rev Cancer, 10, pp. 403-414", "listPosition" : 82, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492499, "link" : "/api/reference/492499", "label" : "83. Szodoray, P., Jonsson, R., The BAFF/APRIL system in systemic autoimmune diseases with a special emphasis on Sjogren's syndrome (2005) Scand J Immunol, 62, pp. 421-428", "listPosition" : 83, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492498, "link" : "/api/reference/492498", "label" : "84. Anderson, L.A., Gadalla, S., Morton, L.M., Landgren, O., Pfeiffer, R., Warren, J.L., Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies (2009) Int J Cancer, 125, pp. 398-405", "listPosition" : 84, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492497, "link" : "/api/reference/492497", "label" : "85. Motz, G.T., Coukos, G., Deciphering and reversing tumor immune suppression (2013) Immunity, 39, pp. 61-73", "listPosition" : 85, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492496, "link" : "/api/reference/492496", "label" : "86. Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system (2009) Nat Rev Immunol, 9, pp. 162-174", "listPosition" : 86, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492495, "link" : "/api/reference/492495", "label" : "87. Gabrilovich, D.I., Chen, H.L., Girgis, K.R., Cunningham, H.T., Meny, G.M., Nadaf, S., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (1996) Nat Med, 2, pp. 1096-1103", "listPosition" : 87, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492494, "link" : "/api/reference/492494", "label" : "88. Moinzadeh, P., Fonseca, C., Hellmich, M., Shah, A.A., Chighizola, C., Denton, C.P., Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma (2014) Arthritis Res Ther, 16, p. R53", "listPosition" : 88, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492493, "link" : "/api/reference/492493", "label" : "89. Shah, A.A., Rosen, A., Hummers, L., Wigley, F., Casciola-Rosen, L., Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies (2010) Arthritis Rheum, 62, pp. 2787-2795", "listPosition" : 89, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492492, "link" : "/api/reference/492492", "label" : "90. Watad, A., McGonagle, D., Bragazzi, N.L., Tiosano, S., Comaneshter, D., Shoenfeld, Y., Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival (2019) Oncoimmunology, 8", "listPosition" : 90, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492491, "link" : "/api/reference/492491", "label" : "91. Baecklund, E., Iliadou, A., Askling, J., Ekbom, A., Backlin, C., Granath, F., Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis (2006) Arthritis Rheum, 54, pp. 692-701", "listPosition" : 91, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492490, "link" : "/api/reference/492490", "label" : "92. Todoric, J., Antonucci, L., Karin, M., Targeting inflammation in Cancer prevention and therapy (2016) Cancer Prev Res (Phila), 9, pp. 895-905", "listPosition" : 92, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492489, "link" : "/api/reference/492489", "label" : "93. Maffeis, M., Notarangelo, L.D., Schumacher, R.F., Soncini, E., Soresina, A., Lanfranchi, A., Primary Immunodeficiencies and oncological risk: the experience of the Children's Hospital of Brescia (2019) Front Pediatr, 7, p. 232", "listPosition" : 93, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492488, "link" : "/api/reference/492488", "label" : "94. Haas, O.A., Primary immunodeficiency and cancer predisposition revisited: embedding two closely related concepts into an integrative conceptual framework (2018) Front Immunol, 9, p. 3136", "listPosition" : 94, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492487, "link" : "/api/reference/492487", "label" : "95. Wick, R.R., Nekolla, E.A., Gaubitz, M., Schulte, T.L., Increased risk of myeloid leukaemia in patients with ankylosing spondylitis following treatment with radium-224 (2008) Rheumatology (Oxford), 47, pp. 855-859", "listPosition" : 95, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492486, "link" : "/api/reference/492486", "label" : "96. Hellgren, K., Dreyer, L., Arkema, E.V., Glintborg, B., Jacobsson, L.T., Kristensen, L.E., F.t.D.S.G. Artis study group, Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers (2017) Ann Rheum Dis, 76, pp. 105-111", "listPosition" : 96, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492485, "link" : "/api/reference/492485", "label" : "97. Askling, J., Klareskog, L., Blomqvist, P., Fored, M., Feltelius, N., Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study (2006) Ann Rheum Dis, 65, pp. 1184-1187", "listPosition" : 97, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492484, "link" : "/api/reference/492484", "label" : "98. Hellgren, K., Smedby, K.E., Backlin, C., Sundstrom, C., Feltelius, N., Eriksson, J.K., Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden (2014) Arthritis Rheumatol, 66, pp. 1282-1290", "listPosition" : 98, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492483, "link" : "/api/reference/492483", "label" : "99. Simard, J.F., Neovius, M., Hagelberg, S., Askling, J., Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study (2010) Arthritis Rheum, 62, pp. 3776-3782", "listPosition" : 99, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492482, "link" : "/api/reference/492482", "label" : "100. Goules, A.V., Tzioufas, A.G., Lymphomagenesis in Sjogren's syndrome: predictive biomarkers towards precision medicine (2019) Autoimmun Rev, 18, pp. 137-143", "listPosition" : 100, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492481, "link" : "/api/reference/492481", "label" : "101. Illes, A., Varoczy, L., Papp, G., Wilson, P.C., Alex, P., Jonsson, R., Aspects of B-cell non-Hodgkin's lymphoma development: a transition from immune-reactivity to malignancy (2009) Scand J Immunol, 69, pp. 387-400", "listPosition" : 101, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492480, "link" : "/api/reference/492480", "label" : "102. Kovacs, L., Szodoray, P., Kiss, E., Secondary tumours in Sjogren's syndrome (2009) Autoimmun Rev, 9, pp. 203-206", "listPosition" : 102, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492479, "link" : "/api/reference/492479", "label" : "103. Kiss, E., Kovacs, L., Szodoray, P., Malignancies in systemic lupus erythematosus (2010) Autoimmun Rev, 9, pp. 195-199", "listPosition" : 103, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492478, "link" : "/api/reference/492478", "label" : "104. Ponyi, A., Constantin, T., Garami, M., Andras, C., Tallai, B., Vancsa, A., Cancer-associated myositis: clinical features and prognostic signs (2005) Ann N Y Acad Sci, 1051, pp. 64-71", "listPosition" : 104, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492477, "link" : "/api/reference/492477", "label" : "105. Andras, C., Ponyi, A., Constantin, T., Csiki, Z., Szekanecz, E., Szodoray, P., Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study (2008) J Rheumatol, 35, pp. 438-444", "listPosition" : 105, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492476, "link" : "/api/reference/492476", "label" : "106. Andras, C., Bodoki, L., Nagy-Vincze, M., Griger, Z., Csiki, E., Danko, K., Retrospective analysis of Cancer-associated myositis patients over the past 3 decades in a Hungarian myositis cohort (2020) Pathol Oncol Res, 26, pp. 1749-1755", "listPosition" : 106, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492475, "link" : "/api/reference/492475", "label" : "107. Bernal-Bello, D., de Tena, J.G., Guillen-Del Castillo, A., Selva-O'Callaghan, A., Callejas-Moraga, E.L., Marin-Sanchez, A.M., Novel risk factors related to cancer in scleroderma (2017) Autoimmun Rev, 16, pp. 461-468", "listPosition" : 107, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492474, "link" : "/api/reference/492474", "label" : "108. Colaci, M., Giuggioli, D., Vacchi, C., Lumetti, F., Iachetta, F., Marcheselli, L., Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian rheumatologic Center and a population-based Cancer registry and review of the literature (2014) Autoimmun Rev, 13, pp. 132-137", "listPosition" : 108, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492473, "link" : "/api/reference/492473", "label" : "109. Czirjak, L., Kumanovics, G., Varju, C., Nagy, Z., Pakozdi, A., Szekanecz, Z., Survival and causes of death in 366 Hungarian patients with systemic sclerosis (2008) Ann Rheum Dis, 67, pp. 59-63", "listPosition" : 109, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492472, "link" : "/api/reference/492472", "label" : "110. Mecoli, C., Rosen, A., Casciola-Rosen, L., Shah, A.A., Advances at the interface of cancer and systemic sclerosis (2020) J Scleroderma Relat Disord, 2020, pp. 1-8", "listPosition" : 110, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492471, "link" : "/api/reference/492471", "label" : "111. Kovacs, A., Baksay, B., Cserenyecz, A., Molnar, K., Takacs, M., Szekanecz, Z., Occurrence of pulmonary rheumatoid nodules following biological therapies (2015) Clin Rheumatol, 34, pp. 1639-1642", "listPosition" : 111, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492469, "link" : "/api/reference/492469", "label" : "112. Reynisdottir, G., Karimi, R., Joshua, V., Olsen, H., Hensvold, A.H., Harju, A., Structural lung changes and local anti-citrulline immunity are early features of anti citrullinated-proteins antibodies positive rheumatoid arthritis (2013) Arthritis Rheum, 66, pp. 31-39", "listPosition" : 112, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492467, "link" : "/api/reference/492467", "label" : "113. Toussirot, E., Roudier, J., Epstein-Barr virus in autoimmune diseases (2008) Best Pract Res Clin Rheumatol, 22, pp. 883-896", "listPosition" : 113, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492466, "link" : "/api/reference/492466", "label" : "114. Zampieri, S., Valente, M., Adami, N., Biral, D., Ghirardello, A., Rampudda, M.E., Polymyositis, dermatomyositis and malignancy: a further intriguing link (2010) Autoimmun Rev, 9, pp. 449-453", "listPosition" : 114, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492465, "link" : "/api/reference/492465", "label" : "115. Masaki, Y., Sugai, S., Lymphoproliferative disorders in Sjogren's syndrome (2004) Autoimmun Rev, 3, pp. 175-182", "listPosition" : 115, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492464, "link" : "/api/reference/492464", "label" : "116. Dong, L., Chen, Y., Masaki, Y., Okazaki, T., Umehara, H., Possible mechanisms of lymphoma development in Sjogren's syndrome (2013) Curr Immunol Rev, 9, pp. 13-22", "listPosition" : 116, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492463, "link" : "/api/reference/492463", "label" : "117. Varoczy, L., Gergely, L., Zeher, M., Szegedi, G., Illes, A., Malignant lymphoma-associated autoimmune diseases–a descriptive epidemiological study (2002) Rheumatol Int, 22, pp. 233-237", "listPosition" : 117, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492462, "link" : "/api/reference/492462", "label" : "118. Nakken, B., Alex, P., Munthe, L., Szekanecz, Z., Szodoray, P., Immune-regulatory mechanisms in systemic autoimmune and rheumatic diseases (2012) Clin Dev Immunol, 2012", "listPosition" : 118, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492461, "link" : "/api/reference/492461", "label" : "119. Tarr, T., Gyorfy, B., Szekanecz, E., Bhattoa, H.P., Zeher, M., Szegedi, G., Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center (2007) Ann N Y Acad Sci, 1108, pp. 76-82", "listPosition" : 119, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492460, "link" : "/api/reference/492460", "label" : "120. Szekanecz, E., Szamosi, S., Gergely, L., Keszthelyi, P., Szekanecz, Z., Szucs, G., Incidence of lymphoma in systemic sclerosis: a retrospective analysis of 218 Hungarian patients with systemic sclerosis (2008) Clin Rheumatol, 27, pp. 1163-1166", "listPosition" : 120, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492459, "link" : "/api/reference/492459", "label" : "121. Szekanecz, E., Szamosi, S., Horvath, A., Nemeth, A., Juhasz, B., Szanto, J., Malignancies associated with systemic sclerosis (2012) Autoimmun Rev, 11, pp. 852-855", "listPosition" : 121, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492458, "link" : "/api/reference/492458", "label" : "122. Cutolo, M., Paolino, S., Pizzorni, C., Possible contribution of chronic inflammation in the induction of cancer in rheumatic diseases (2014) Clin Exp Rheumatol, 32, pp. 839-847", "listPosition" : 122, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492457, "link" : "/api/reference/492457", "label" : "123. Elinav, E., Nowarski, R., Thaiss, C.A., Hu, B., Jin, C., Flavell, R.A., Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms (2013) Nat Rev Cancer, 13, pp. 759-771", "listPosition" : 123, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492456, "link" : "/api/reference/492456", "label" : "124. Giat, E., Ehrenfeld, M., Shoenfeld, Y., Cancer and autoimmune diseases (2017) Autoimmun Rev, 16, pp. 1049-1057", "listPosition" : 124, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492455, "link" : "/api/reference/492455", "label" : "125. Szekanecz, Z., Szekanecz, E., Bako, G., Shoenfeld, Y., Malignancies in autoimmune rheumatic diseases - a mini-review (2011) Gerontology, 57, pp. 3-10", "listPosition" : 125, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492454, "link" : "/api/reference/492454", "label" : "126. Szekanecz, E., Andras, C., Sandor, Z., Antal-Szalmas, P., Szanto, J., Tamasi, L., Malignancies and soluble tumor antigens in rheumatic diseases (2006) Autoimmun Rev, 6, pp. 42-47", "listPosition" : 126, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492577, "link" : "/api/reference/492577", "label" : "127. Rotte, A., D'Orazi, G., Bhandaru, M., Nobel committee honors tumor immunologists (2018) J Exp Clin Cancer Res, 37, p. 262", "listPosition" : 127, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492576, "link" : "/api/reference/492576", "label" : "128. McGonagle, D., Bragazzi, N.L., Amital, H., Watad, A., Mechanistic classification of immune checkpoint inhibitor toxicity as a pointer to minimal treatment strategies to further improve survival (2020) Autoimmun Rev, 19", "listPosition" : 128, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492562, "link" : "/api/reference/492562", "label" : "129. Abdel-Wahab, N., Shah, M., Suarez-Almazor, M.E., Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports (2016) PLoS One, 11", "listPosition" : 129, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492548, "link" : "/api/reference/492548", "label" : "130. Younus, J., Kligman, L., Management of aromatase inhibitor-induced arthralgia (2010) Curr Oncol, 17, pp. 87-90", "listPosition" : 130, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492470, "link" : "/api/reference/492470", "label" : "131. Catrina, A.I., Deane, K.D., Scher, J.U., Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis (2016) Rheumatology (Oxford), 55, pp. 391-402", "listPosition" : 131, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 492468, "link" : "/api/reference/492468", "label" : "132. Pijpe, J., van Imhoff, G.W., Spijkervet, F.K., Roodenburg, J.L., Wolbink, G.J., Mansour, K., Rituximab treatment in patients with primary Sjogren's syndrome: an open-label phase II study (2005) Arthritis Rheum, 52, pp. 2740-2750", "listPosition" : 132, "published" : false, "snippet" : true } ], "hasCitationDuplums" : false, "inSelectedPubs" : "10013912,10043694,10003464,10060464", "userChangeableUntil" : "2020-12-06T12:44:38.709+0000", "directInstitutesForSort" : "Belgyógyászati Intézet (DE / ÁOK); Budai Irgalmasrendi Kórház Kht.; Klinikai Immunológiai Tanszék (DE / ÁOK / BelgyI); Laboratóriumi Medicina Intézet (DE / ÁOK); Onkológiai Tanszék (DE / ÁOK); Reumatológiai Tanszék (DE / ÁOK / BelgyI)", "ownerAuthorCount" : 12, "ownerInstituteCount" : 38, "directInstituteCount" : 6, "authorCount" : 19, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/31646872", "label" : "Szekanecz Z. et al. Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases. (2020) AUTOIMMUNITY REVIEWS 1568-9972 1873-0183 19 11", "template" : "